Successful retrial of ECT two months after ECT-induced takotsubo cardiomyopathy

American Journal of Psychiatry

Volumn 166, Issue 8, 2009, Pages 857-862

  Kent, Laura K ^a   Weston, Christi A ^b   Heyer, Eric J ^b   Sherman, Warren ^b   Prudic, Joan ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ARIPIPRAZOLE; ATORVASTATIN; ATROPINE; BENZATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DOCUSATE SODIUM; DONEPEZIL; DULOXETINE; ESMOLOL; ESOMEPRAZOLE; FLUOXETINE; LAMOTRIGINE; LISINOPRIL; LORAZEPAM; METHOHEXITAL; METOPROLOL; MIRTAZAPINE; NICARDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTRALINE; SUXAMETHONIUM; UNINDEXED DRUG; VENLAFAXINE; PSYCHOTROPIC AGENT;

AGED; ANESTHESIA INDUCTION; ANESTHESIST; ANXIETY DISORDER; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; BRADYKINESIA; CARDIOVASCULAR EFFECT; CASE REPORT; CLINICAL PROTOCOL; COGNITIVE DEFECT; CONSTIPATION; DELIRIUM; DEPRESSION; DISEASE COURSE; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCONVULSIVE THERAPY; EVENING DOSAGE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; GERIATRIC PATIENT; HAMILTON SCALE; HEART CATHETERIZATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; HEART VENTRICULOGRAPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSOMNIA; LIFE STRESS; LOADING DRUG DOSE; MAJOR DEPRESSION; MEMORY DISORDER; MENTAL HEALTH CARE; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; PANIC; PATIENT MONITORING; POLYPHARMACY; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; RETREATMENT; RISK BENEFIT ANALYSIS; SIDE EFFECT; TAKOTSUBO CARDIOMYOPATHY; TERRORISM; TIETZE SYNDROME; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA; BRAIN VENTRICULOGRAPHY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; HEMISPHERIC DOMINANCE; IATROGENIC DISEASE; METHODOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RADIOGRAPHY; STATISTICS;

AGED; CEREBRAL VENTRICULOGRAPHY; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IATROGENIC DISEASE; PSYCHOTROPIC DRUGS; SEPTEMBER 11 TERRORIST ATTACKS; TAKOTSUBO CARDIOMYOPATHY; TREATMENT OUTCOME;

EID: 68149136896     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08081278     Document Type: Article

References (28)

1. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M: [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]. J Cardiol 1991; 21:203-214 (Japanese)
2. Pavin D, Le Breton H, Daubert C: Human stress cardiomyopathy mimicking acute myocardial syndrome. Heart 1997; 78:509-511 (Pubitemid 27515115)
3. Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R, Morii I; Angina Pectoris-Myocardial Infarction Investigations in Japan: Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction (Angina Pectoris-Myocardial Infarction Investigations in Japan). J Am Coll Cardiol 2001; 38:11-18
4. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC: Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005; 352:539-548 (Pubitemid 40204667)
5. Wittstein IS: The broken heart syndrome. Cleve Clin J Med 2007; 74(suppl 1):S17-S22
6. de Gregorio C, Grimaldi P, Lentini C: Left ventricular thrombus formation and cardioembolic complications in patients with Takotsubo-like syndrome: a systematic review. Int J Cardiol 2008; 131:18-24
7. Dec GW Jr, Stern TA, Welch C: The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values: a prospective study of depressed hospitalized in-patients. JAMA 1985; 253:2525-2529
8. Shiah IS, Yatham LN, Srisurapanont M, Lam RW, Tam EM, Zis AP: Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? a double-blind, placebo-controlled pilot study. J Clin Psychopharmacol 2000; 20:373-378 (Pubitemid 30318369)
9. Prudic J, Sackeim HA, Decina P, Hopkins N, Ross FR, Malitz S: Acute effects of ECT on cardiovascular functioning: relations to patient and treatment variables. Acta Psychiatr Scand 1987; 75:344-351 (Pubitemid 17063969)
10. Lane RD, Zeitlin SB, Abrams R, Swartz CM: Differential effects of right unilateral and bilateral ECT on heart rate. Am J Psychiatry 1989; 146:1041-1043 (Pubitemid 19197984)
11. Mayur PM, Gangadhar BN, Girish K, Prasad KM, Subbakrishna DK, Janakiramiah N: Acute post-ECT cardiovascular response: a comparison of threshold right unilateral and bilateral ECT. J ECT 1998; 14:94-98 (Pubitemid 28259174)
12. O'Reardon JP, Lott JP, Akhtar UW, Cristancho P, Weiss D, Jones N: Acute coronary syndrome (Takotsubo cardiomyopathy) following electroconvulsive therapy in the absence of significant coronary artery disease: case report and review of the literature. J ECT 2008; 24:277-280
13. Ring BS, Parnass SM, Shulman RB, Phelan J, Khan SA: Cardiogenic shock after electroconvulsive therapy. Anesthesiology 1996; 84:1511-1513
14. Fuenmayor AJ, el Fakih Y, Moreno J, Fuenmayor AM: Effects of electroconvulsive therapy on cardiac function in patients without heart disease. Cardiology 1997; 88:254-257
15. Pollack MH, Rosenbaum JF, Cassem NH: Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis 1985; 173:118-119 (Pubitemid 15131522)
16. Fitzgerald JD: Propranolol-induced depression. Br Med J 1967; 2:372-373
17. Patten SB: Propranolol and depression: evidence from the antihypertensive trials. Can J Psychiatry 1990; 35:257-259
18. Stoudemire A, Brown JT, Harris RT, Blessing-Feussner C, Roberts JH, Nichols JC, Houpt JL: Propranolol and depression: a reevaluation based on a pilot clinical trial. Psychiatr Med 1984; 2:211-218
19. Schleifer SJ, Slater WR, Macari-Hinson MM, Coyle DA, Kahn M, Zucker HD, Gorlin R: Digitalis and beta-blocking agents: effects on depression following myocardial infarction. Am Heart J 1991; 121:1397-1402
20. van Melle JP, Verbeek DE, van den Berg MP, Ormel J, van der Linde MR, de Jonge P: Beta-blockers and depression after myocardial infarction: a multicenter prospective study. J Am Coll Cardiol 2006; 48:2209-2214 (Pubitemid 44855428)
21. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM: Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002; 288:351-357 (Pubitemid 34761614)
22. McCall WV, Zvara D, Brooker R, Arias L: Effect of esmolol pre-treatment on EEG seizure morphology in RUL ECT. Convuls Ther 1997; 13:175-180 (Pubitemid 27439132)
23. McCully RB, Karon BL, Rummans TA, Black JL, Andreen KM, Oh JK, Seward JB, Tajik AJ: Frequency of left ventricular dysfunction after electroconvulsive therapy. Am J Cardiol 2003; 91:1147-1150 (Pubitemid 36514942)
24. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA: Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993; 150:904-909 (Pubitemid 23156771)
25. Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, Roiser JP, Neumeister A, Meyers N, Charney DS, Drevets WC: Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 2008; 65:521-531 (Pubitemid 351645048)
26. Saber AJ, Cain DP: Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists. Neuropsychopharmacology 2003; 28:1247-1256
27. Vishne T, Aronov S, Amiaz R, Etchin A, Grunhaus L: Remifentanil supplementation of propofol during electroconvulsive therapy: effect on seizure duration and cardiovascular stability. J ECT 2005; 21:235-238 (Pubitemid 41772226)
28. Prudic J, Fitzsimons L, Nobler MS, Sackeim HA: Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study. Neuropsychopharmacology 1999; 21:285-293 (Pubitemid 29304588)